Patents by Inventor Wendell David Zollinger

Wendell David Zollinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MENINGOCOCCAL MULTIVALENT NATIVE OUTER MEMBRANE VESICLE VACCINE, METHODS OF MAKING AND USE THEREOF
    Publication number: 20170100471
    Abstract: The present technology provides vaccine compositions comprising native outer membrane vesicles (NOMVs) from at least one genetically modified strain of Neisseria which provides protective immunity to meningococcal disease, more preferably subtype B meningococcal disease. The present technology further provides methods of immunizing an animal or human against meningococcal disease comprising administering the vaccine composition of the present invention.
    Type: Application
    Filed: July 12, 2016
    Publication date: April 13, 2017
    Inventors: Wendell David Zollinger, Mikhail Donets, Deborah Schmiel, Boris Ionin, Ryan Marques, Elizabeth Ellen Moran
  • Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
    Patent number: 9387239
    Abstract: The present technology provides vaccine compositions comprising native outer membrane vesicles (NOMVs) from at least one genetically modified strain of Neisseria which provides protective immunity to meningococcal disease, more preferably subtype B meningococcal disease. The present technology further provides methods of immunizing an animal or human against meningococcal disease comprising administering the vaccine composition of the present invention.
    Type: Grant
    Filed: June 1, 2009
    Date of Patent: July 12, 2016
    Assignee: U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND
    Inventors: Wendell David Zollinger, Mikhail Donets, Deborah Schmiel, Boris Ionin, Ryan Marques, Elizabeth Ellen Moran
  • MENINGOCOCCAL MULTIVALENT NATIVE OUTER MEMBRANE VESICLE VACCINE, METHODS OF MAKING AND USE THEREOF
    Publication number: 20110182942
    Abstract: The present technology provides vaccine compositions comprising native outer membrane vesicles (NOMVs) from at least one genetically modified strain of Neisseria which provides protective immunity to meningococcal disease, more preferably subtype B meningococcal disease. The present technology further provides methods of immunizing an animal or human against meningococcal disease comprising administering the vaccine composition of the present invention.
    Type: Application
    Filed: June 1, 2009
    Publication date: July 28, 2011
    Inventor: Wendell David Zollinger